Nephros Inc
NEPH5.030USD
-0.040-0.79%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
53.45MMarket Cap
35.95P/E TTM
More Details of Nephros Inc Company
Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
Nephros Inc Info
Ticker SymbolNEPH
Company nameNephros Inc
IPO dateSep 21, 2004
CEOBanks (Robert)
Number of employees31
Security typeOrdinary Share
Fiscal year-endSep 21
Address380 Lackawanna Pl
CitySOUTH ORANGE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code07079-1704
Phone12013435202
Websitehttps://www.nephros.com/
Ticker SymbolNEPH
IPO dateSep 21, 2004
CEOBanks (Robert)
Company Executives of Nephros Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Arthur H. Amron, J.D.
Mr. Arthur H. Amron, J.D.
Director
Director
131.27K
+4.28%
Mr. Oliver J. Spandow
Mr. Oliver J. Spandow
Independent Director
Independent Director
122.88K
+7.00%
Mr. Joseph Harris
Mr. Joseph Harris
Independent Director
Independent Director
--
--
Mr. Robert Banks
Mr. Robert Banks
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Judith (Judy) Krandel
Ms. Judith (Judy) Krandel
Chief Financial Officer
Chief Financial Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Arthur H. Amron, J.D.
Mr. Arthur H. Amron, J.D.
Director
Director
131.27K
+4.28%
Mr. Oliver J. Spandow
Mr. Oliver J. Spandow
Independent Director
Independent Director
122.88K
+7.00%
Mr. Joseph Harris
Mr. Joseph Harris
Independent Director
Independent Director
--
--
Mr. Robert Banks
Mr. Robert Banks
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Judith (Judy) Krandel
Ms. Judith (Judy) Krandel
Chief Financial Officer
Chief Financial Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Wexford Capital LP
34.04%
Topline Capital Management, LLC
5.60%
Pessin (Sandra F)
3.48%
Pessin (Norman H)
3.24%
The Vanguard Group, Inc.
2.65%
Other
51.00%
Shareholders
Shareholders
Proportion
Wexford Capital LP
34.04%
Topline Capital Management, LLC
5.60%
Pessin (Sandra F)
3.48%
Pessin (Norman H)
3.24%
The Vanguard Group, Inc.
2.65%
Other
51.00%
Shareholder Types
Shareholders
Proportion
Hedge Fund
40.69%
Individual Investor
11.31%
Investment Advisor
4.63%
Investment Advisor/Hedge Fund
1.22%
Research Firm
0.52%
Venture Capital
0.14%
Other
41.50%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
31
4.82M
45.37%
-29.24K
2025Q2
39
5.84M
55.12%
-183.12K
2025Q1
40
6.02M
56.88%
-61.37K
2024Q4
40
6.01M
57.04%
+401.71K
2024Q3
41
5.63M
53.41%
-573.67K
2024Q2
43
5.67M
53.74%
-568.79K
2024Q1
45
5.62M
53.39%
-435.05K
2023Q4
45
5.58M
53.01%
-868.28K
2023Q3
47
5.50M
52.47%
-1.04M
2023Q2
46
5.49M
52.36%
-963.19K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Wexford Capital LP
3.61M
34.04%
+7.53K
+0.21%
Jun 30, 2025
Topline Capital Management, LLC
477.45K
4.5%
+55.36K
+13.12%
Jun 30, 2025
Pessin (Sandra F)
369.71K
3.49%
-59.73K
-13.91%
Apr 22, 2025
Pessin (Norman H)
344.13K
3.25%
--
--
Apr 22, 2025
The Vanguard Group, Inc.
323.44K
3.05%
+119.28K
+58.43%
Jun 30, 2025
Amron (Arthur H)
125.88K
1.19%
--
--
Apr 22, 2025
Bard Associates Inc.
131.12K
1.24%
-12.10K
-8.45%
Jun 30, 2025
Spandow (Oliver J)
114.84K
1.08%
--
--
Apr 22, 2025
Pessin (Brian L.)
95.69K
0.9%
-4.00K
-4.01%
Apr 22, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Dimensional US Core Equity 1 ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
Dimensional US Core Equity 1 ETF
Proportion0%
DFA Dimensional US Sustainability Core 1 ETF
Proportion0%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Nephros Inc?
The top five shareholders of Nephros Inc are:
Wexford Capital LP holds 3.61M shares, accounting for 34.04% of the total shares.
Topline Capital Management, LLC holds 477.45K shares, accounting for 4.50% of the total shares.
Pessin (Sandra F) holds 369.71K shares, accounting for 3.49% of the total shares.
Pessin (Norman H) holds 344.13K shares, accounting for 3.25% of the total shares.
The Vanguard Group, Inc. holds 323.44K shares, accounting for 3.05% of the total shares.
Wexford Capital LP holds 3.61M shares, accounting for 34.04% of the total shares.
Topline Capital Management, LLC holds 477.45K shares, accounting for 4.50% of the total shares.
Pessin (Sandra F) holds 369.71K shares, accounting for 3.49% of the total shares.
Pessin (Norman H) holds 344.13K shares, accounting for 3.25% of the total shares.
The Vanguard Group, Inc. holds 323.44K shares, accounting for 3.05% of the total shares.
What are the top three shareholder types of Nephros Inc?
The top three shareholder types of Nephros Inc are:
Wexford Capital LP
Topline Capital Management, LLC
Pessin (Sandra F)
Wexford Capital LP
Topline Capital Management, LLC
Pessin (Sandra F)
How many institutions hold shares of Nephros Inc (NEPH)?
As of 2025Q3, 31 institutions hold shares of Nephros Inc, with a combined market value of approximately 4.82M, accounting for 45.37% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -9.75%.
What is the biggest source of revenue for Nephros Inc?
In --, the -- business generated the highest revenue for Nephros Inc, amounting to -- and accounting for --% of total revenue.
